DRUG · Unmapped registry intervention
HR17031 injection
Find medicine records ·
Find other trials using this name
Clinical trial
A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
NCT06871761
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
insulin glargine
Normalized identity: insulin glargineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Adult Patients With Type 2 Diabetesunresolved
Interventions
insulin glargineDRUG · verified · RxNorm: insulin glargine
Sponsors & collaborators
Jiangsu HengRui Medicine Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06871761 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.